Opening FreeMind’s 2017 webinar series is an introduction to the SBIR and STTR mechanisms which account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we discussed process for applying, guidelines, key success components and insight into increasing chances for award.

 

View slide deck

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View the SBIR/STTR webinar slide deck

To discuss the relevance of the SBIR/STTR programs to your R&D and to learn about non-dilutive funding that may be available to your organization, send us a note and we’ll get in touch with you directly!

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) supports research on many of the most common, costly, and chronic conditions to improve health.

With a FY2016 budget of over $1.8 Billion, the NIDDK supports R&D from basic research and early discovery stage projects all the way through late stage clinical trials. The NIDDK funds research in a wide variety of topics including Diabetes, Weight Management, Digestive, Kidney, Liver, Urologic and Endocrine Diseases, Nutrition, and many more.

In this webinar we cover:
• The various programs and mechanisms
• The application process
• Guidelines and regulations
• Key success components
• Insight into increasing chances for award

View the NIDDK webinar slide deck

To discuss the relevance of the NIDDK to your R&D and to learn about non-dilutive funding that may be available to your organization, send us a note and we’ll get in touch with you directly!

Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences.

Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private foundations. The NIH alone annually funds over $15B to pre-clinical stage R&D in the life sciences.

In this webinar we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View the webinar slide deck

To discuss funding opportunities for pre-clinical stage R&D and to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!

The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military.

With a FY2016 budget of over $800 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast Cancer and Multiple Sclerosis. There are several additional Peer Reviewed topics such as Alzheimer’s and Cancer, and others.

In this webinar we discuss the various programs, the process for applying, guidelines, key success components and insight into increasing chances for award.

View the webinar slide deck
To discuss the CDMRPs or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!

Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences.

Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from the DOD.

In this webinar we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View the webinar slide deck

To discuss funding opportunities for clinical stage R&D and to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!

SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics.

SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, devices, etc.

In this webinar we discuss process for applying, guidelines, key success components and insight into increasing chances for award.

View the webinar slide deck

To discuss SBIRs, STTRs, or to learn about other non-dilutive funding that may be relevant to your organization, send us a note and we’ll get in touch with you directly!

NIH alone awards roughly $6B annually to Cancer related R&D grants and contracts. The scope of funding support covers much of the R&D cycle with an emphasis on pre-clinical work, and may cover clinical stage activities as well.

In the upcoming webinar in the series of summer educational webinars FreeMind experts will discuss key cancer related opportunities, mainly within the National Cancer Institute (NCI), that are available for Life Science organizations.